Thomas Armel

2010201120122013201420152016201720182019202020212022202320246 10 31 62 71 50 40 49 30 33 32 24 18 20 5

Public access

5 articles

0 articles

available

not available

Based on funding mandates

Pamela SilverProfessor of Systems Biology, Harvard Medical SchoolVerified email at hms.harvard.edu
Jason LohmuellerAssistant Professor, University of PittsburghVerified email at pitt.edu
Leslie LeinwandDistinguished Professor of Molecular, Cellular and Developmental Biology and Chief Scientific Officer of the BioFrontiers Institute, University of Colorado BoulderVerified email at colorado.edu
Abhishek GargEPFL, Harvard, NovartisVerified email at novartis.com

Thomas Armel

Partner/Principal at EY-Parthenon

Verified email at parthenon.ey.com


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Engineering synthetic TAL effectors with orthogonal target sites A Garg, JJ Lohmueller, PA Silver, TZ Armel Nucleic acids research 40 (15), 7584-7595, 2012	213	2012
A tunable zinc finger-based framework for Boolean logic computation in mammalian cells JJ Lohmueller, TZ Armel, PA Silver Nucleic acids research 40 (11), 5180-5187, 2012	154	2012
Mutations in the β-myosin rod cause myosin storage myopathy via multiple mechanisms TZ Armel, LA Leinwand Proceedings of the National Academy of Sciences 106 (15), 6291-6296, 2009	58	2009
Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes TZ Armel, LA Leinwand Journal of molecular and cellular cardiology 48 (5), 1007-1013, 2010	40	2010
A mutation in the β-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype TZ Armel, LA Leinwand Biochemical and biophysical research communications 391 (1), 352-356, 2010	22	2010

The system can't perform the operation now. Try again later.

Articles 1–5

Citations per year